MYCOBACTERIUM-KANSASII INFECTIONS IN WESTERN-AUSTRALIA (1962-1987)
MYCOBACTERIUM-KANSASII INFECTIONS IN WESTERN-AUSTRALIA (1962-1987)
复制标题
DOI：
10.1016/s0954-6111(06)80082-x
复制
发表时间：
1991-05-01
影响因子：
4.3
通讯作者：
PANG, SC
中科院分区：
文献类型：
--
作者：
PANG, SC
本文回顾了西澳大利亚州26年来分离出的81例堪萨斯分枝杆菌患者的记录。39例40次感染被认为是由toM引起的疾病。堪萨斯州：肺部36例（90%），关节2例（5%），皮肤（2.5%）和淋巴结各1例（2.5%）。平均发病率为每10万人每年0.14，最高的是杰拉尔顿中西部地区（0.57）。男女比例为4:1，平均年龄50岁（sd14.5）。肺部疾病的男女比例为3.1:1，平均年龄53岁（sd11）， 42%是矿工或前矿工，91%是吸烟者或前吸烟者。几乎97%的感染者是白种人，没有土著居民。药物治疗非常成功，特别是利福平/乙胺丁醇联合治疗，12个月似乎足够。与42例隔离不显著的患者相比，肺部疾病患者的人口统计学存在差异。
The records of 81 patients with isolations ofMycobacterium kansasiiin Western Australia over 26 years have been reviewed. Thirty-nine individuals with 40 episodes of infection were considered to have disease due toM. kansasii: 36 in the lungs (90%), two in the joints (5%), and one each in the skin (2·5%) and the lymph nodes (2·5%). The average incidence rate per 100 000 per year was 0·14 for the state with the highest in the Geraldton Mid-west region (0·57). The male:female ratio was 4:1 and the mean age 50 years (sd14·5). For pulmonary disease the male:female ratio was 3·5:1, the mean age 53 years (sd11), 42% being miners or ex-miners and 91% smokers or ex-smokers. Almost 97% of those infected were Caucasian and none were Aboriginal. Drug treatment was highly successful, particularly with the rifampicin/ethambutol combination, where 12 months appeared to be adequate. There are differences in the demography of the patients having pulmonary disease compared to the 42 with insignificant isolations.